CB
Colin Bristow UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
57.9%
Neutral
42.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $112 |
4%
downside
| 2 | – |
–
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $553 |
36%
upside
| 4 | -4.2% |
0
%
| 5 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $80 |
21%
upside
| 2 | +17% |
0
%
| 29 Jul ‘25 2 months ago |
|
|
|
Buy
Maintained
| $5 |
46%
upside
| 1 | +19% |
0
%
| 17 Jun ‘25 3 months ago |
|
|
|
Buy
Maintained
| $1 |
39%
downside
| 2 | +105% |
0
%
| 21 May ‘25 4 months ago |
|
|
|
Neutral
Downgraded
| $17 |
0%
downside
| 1 | – |
–
| 22 Apr ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $319 |
10%
upside
| 2 | – |
–
| 14 Apr ‘25 6 months ago |
|
|
|
Buy
Maintained
| $4 |
87%
upside
| 1 | +74% |
0
%
| 28 Mar ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $7 |
17%
downside
| 1 | – |
–
| 14 Feb ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $28 |
13%
upside
| 2 | – |
–
| 5 Feb ‘25 8 months ago |
|
|
|
Buy
Maintained
| $120 |
40%
upside
| 1 | -15% |
0
%
| 8 Jan ‘25 9 months ago |
|